Global Spinal Muscular Atrophy (SMA) Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 159744
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 121
  • list Medical Devices

Spinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration.

Scope of the Report:

This report focuses on the Spinal Muscular Atrophy (SMA) Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

North America dominates the global market for SMA treatment due to the high prevalence of SMA and increased adoption of SMA treatment options in the region.

The worldwide market for Spinal Muscular Atrophy (SMA) Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Pfizer

Isis Pharmaceuticals

Biogen Idec

Boehringer Ingelheim

F. Hoffmann-La Roche

Regeneron Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Type I Spinal Muscular Atrophy (SMA)

Type II Spinal Muscular Atrophy (SMA)

Type III Spinal Muscular Atrophy (SMA)

Market Segment by Applications, can be divided into

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Others

There are 15 Chapters to deeply display the global Spinal Muscular Atrophy (SMA) Treatment market.

Chapter 1, to describe Spinal Muscular Atrophy (SMA) Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Spinal Muscular Atrophy (SMA) Treatment, with sales, revenue, and price of Spinal Muscular Atrophy (SMA) Treatment, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Spinal Muscular Atrophy (SMA) Treatment, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Spinal Muscular Atrophy (SMA) Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Spinal Muscular Atrophy (SMA) Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Spinal Muscular Atrophy (SMA) Treatment Introduction

1.2 Market Analysis by Type

1.2.1 Type I Spinal Muscular Atrophy (SMA)

1.2.2 Type II Spinal Muscular Atrophy (SMA)

1.2.3 Type III Spinal Muscular Atrophy (SMA)

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Ambulatory Surgical Centers

1.3.3 Diagnostic Centers

1.3.4 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Spinal Muscular Atrophy (SMA) Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Isis Pharmaceuticals

2.2.1 Business Overview

2.2.2 Spinal Muscular Atrophy (SMA) Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Biogen Idec

2.3.1 Business Overview

2.3.2 Spinal Muscular Atrophy (SMA) Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Boehringer Ingelheim

2.4.1 Business Overview

2.4.2 Spinal Muscular Atrophy (SMA) Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 F. Hoffmann-La Roche

2.5.1 Business Overview

2.5.2 Spinal Muscular Atrophy (SMA) Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Regeneron Pharmaceuticals

2.6.1 Business Overview

2.6.2 Spinal Muscular Atrophy (SMA) Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Spinal Muscular Atrophy (SMA) Treatment Manufacturer Market Share in 2017

3.3.2 Top 6 Spinal Muscular Atrophy (SMA) Treatment Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Spinal Muscular Atrophy (SMA) Treatment Market Analysis by Regions

4.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Market Share by Regions

4.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Regions (2013-2018)

4.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue and Market Share by Regions (2013-2018)

4.2 North America Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

4.3 Europe Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

4.5 South America Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

5 North America Spinal Muscular Atrophy (SMA) Treatment by Countries

5.1 North America Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Market Share by Countries

5.1.1 North America Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Countries (2013-2018)

5.1.2 North America Spinal Muscular Atrophy (SMA) Treatment Revenue and Market Share by Countries (2013-2018)

5.2 United States Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

5.3 Canada Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

5.4 Mexico Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

6 Europe Spinal Muscular Atrophy (SMA) Treatment by Countries

6.1 Europe Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Market Share by Countries

6.1.1 Europe Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Spinal Muscular Atrophy (SMA) Treatment Revenue and Market Share by Countries (2013-2018)

6.2 Germany Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

6.3 UK Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

6.4 France Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

6.5 Russia Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

6.6 Italy Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

7 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment by Countries

7.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue and Market Share by Countries (2013-2018)

7.2 China Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

7.3 Japan Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

7.4 Korea Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

7.5 India Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

8 South America Spinal Muscular Atrophy (SMA) Treatment by Countries

8.1 South America Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Market Share by Countries

8.1.1 South America Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Countries (2013-2018)

8.1.2 South America Spinal Muscular Atrophy (SMA) Treatment Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

8.3 Argentina Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

8.4 Colombia Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

9 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment by Countries

9.1 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

9.3 UAE Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

9.4 Egypt Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

9.5 Nigeria Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

9.6 South Africa Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate (2013-2018)

10 Global Spinal Muscular Atrophy (SMA) Treatment Market Segment by Type

10.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Type (2013-2018)

10.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue and Market Share by Type (2013-2018)

10.2 Type I Spinal Muscular Atrophy (SMA) Sales Growth and Price

10.2.1 Global Type I Spinal Muscular Atrophy (SMA) Sales Growth (2013-2018)

10.2.2 Global Type I Spinal Muscular Atrophy (SMA) Price (2013-2018)

10.3 Type II Spinal Muscular Atrophy (SMA) Sales Growth and Price

10.3.1 Global Type II Spinal Muscular Atrophy (SMA) Sales Growth (2013-2018)

10.3.2 Global Type II Spinal Muscular Atrophy (SMA) Price (2013-2018)

10.4 Type III Spinal Muscular Atrophy (SMA) Sales Growth and Price

10.4.1 Global Type III Spinal Muscular Atrophy (SMA) Sales Growth (2013-2018)

10.4.2 Global Type III Spinal Muscular Atrophy (SMA) Price (2013-2018)

11 Global Spinal Muscular Atrophy (SMA) Treatment Market Segment by Application

11.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Ambulatory Surgical Centers Sales Growth (2013-2018)

11.4 Diagnostic Centers Sales Growth (2013-2018)

11.5 Others Sales Growth (2013-2018)

12 Spinal Muscular Atrophy (SMA) Treatment Market Forecast (2018-2023)

12.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Growth Rate (2018-2023)

12.2 Spinal Muscular Atrophy (SMA) Treatment Market Forecast by Regions (2018-2023)

12.2.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Forecast (2018-2023)

12.2.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Forecast (2018-2023)

12.2.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Forecast (2018-2023)

12.2.4 South America Spinal Muscular Atrophy (SMA) Treatment Market Forecast (2018-2023)

12.2.5 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Forecast (2018-2023)

12.3 Spinal Muscular Atrophy (SMA) Treatment Market Forecast by Type (2018-2023)

12.3.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales Forecast by Type (2018-2023)

12.3.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Share Forecast by Type (2018-2023)

12.4 Spinal Muscular Atrophy (SMA) Treatment Market Forecast by Application (2018-2023)

12.4.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales Forecast by Application (2018-2023)

12.4.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Spinal Muscular Atrophy (SMA) Treatment Picture

Table Product Specifications of Spinal Muscular Atrophy (SMA) Treatment

Figure Global Sales Market Share of Spinal Mu

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery